SBH
ASTH icon

Segall Bryant & Hamill’s Astrana Health ASTH Stock Holding History

Segall Bryant & Hamill’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
+25,826
New +$929K 0.01% 529

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Segall Bryant & Hamill's ASTH Position: Q2 2026 in Review

Segall Bryant & Hamill opened a new position in Astrana Health (ASTH) in Q2 2026: 25,826 shares worth $1.2M. The stake represents 0.01% of the portfolio and ranks #529 among its holdings.

209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Segall Bryant & Hamill held 25,826 shares of Astrana Health worth $1.2M as of Q2 2026.
  • Astrana Health was a new Segall Bryant & Hamill position in Q2 2026.
  • Astrana Health made up 0.01% of Segall Bryant & Hamill's portfolio in Q2 2026, its #529 holding.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.